StockMarketWire.com - Citigroup today upgrades its investment rating on Hikma Pharmaceuticals PLC [LON:HIK] to buy (from neutral) and set its price target at 1250p.

Story provided by StockMarketWire.com

Broker Forecasts data provided by www.sharesmagazine.co.uk